FBB Neuraceq™, April 2020
The first of April 2020 FBB Neuraceq™.has been accepted by the compulsory national health insurance for reimbursement.
The first of April 2020 FBB Neuraceq™.has been accepted by the compulsory national health insurance for reimbursement.
Swissmedic has granted SWAN Isotopen AG a temporary market approval for SWAN-PSMA-1007.